Skip to main content

Canadian Pharmacist Qualifying Exam Practice · Question

A patient with newly diagnosed type 2 diabetes is prescribed gliclazide. What is the primary mechanism of action of this medication?

Gliclazide is a sulfonylurea that stimulates insulin release from the pancreatic beta cells, thereby lowering blood glucose. It is commonly used in type 2 diabe

Start free practice for Canadian Pharmacist Qualifying Exam Practice

300 questions · no signup required · 40 free questions per day

Start Practice →

Question: A patient with newly diagnosed type 2 diabetes is prescribed gliclazide. What is the primary mechanism of action of this medication?

Answer options: ✅ Increases insulin secretion from pancreatic beta cells

  • Decreases hepatic glucose production
  • Improves insulin sensitivity in peripheral tissues
  • Slows carbohydrate absorption in the gut

Correct answer: Increases insulin secretion from pancreatic beta cells

Explanation: Gliclazide is a sulfonylurea that stimulates insulin release from the pancreatic beta cells, thereby lowering blood glucose. It is commonly used in type 2 diabetes.

Start free practice for Canadian Pharmacist Qualifying Exam Practice

300 questions · no signup required · 40 free questions per day

Start Practice →

More about Canadian Pharmacist Qualifying Exam Practice

Related Questions

More for Canadian Pharmacist Qualifying Exam Practice candidates

Ready to practice?

Free, no signup required. Build a wrong-question list as you go.

Start Free Canadian Pharmacist Qualifying Exam Practice Practice →

Related courses

Other Canadian certifications candidates often prepare for alongside this one.